Capsulution Nanoscience AG - Further Fundamental Patent Grant is Imminent
Following a recent notice from the European Patent Office, Capsulution Nanoscience AG announced that a further fundamental patent grant for its nano- and microencapsulation technology - known as the LBL-Technology® - is imminent. The patent with the number EP 1064087 covers the manufacture of multifunctional nano- and micron-sized capsules. The tiny capsules can be filled with pharmaceutical drug compounds as well as with other active substances. On the basis of the LBL-Technology® Capsulution develops advanced drug delivery systems, which bring drugs more safely and effectively to the right site of the body. The LBL-Technology® represents a versatile encapsulation system. For the actual encapsulation, a wide range of FDA-approved polymers can be used. In addition, the capsules' surface can be functionalized to suit a targeted release in the human body.
Most read news
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.